Google’s Health Moonshot Comes Back to Earth

Verily Life Sciences is beginning a four-year health-tracking study that likely costs eight figures. The first of 10,000 volunteers will soon walk into labs at Stanford and Duke to subject themselves to a two-day battery of tests. Opening on April 19, the study is called Baseline, as in a starting point for what healthy biometric data should look like. It’s the first serious public test for Verily Life Sciences, formerly Google Life Sciences.